Intellectual Property Contracts & Agreements in the Health Care Equipment & Supplies Industry

603 Contracts & Agreements

Browse by Subcategory

License Agreements (592 contracts from 163 companies)
Trademark Agreements (11 | 10)

Browse by Company

ABIOMED Inc (1 contract)
ACCURAY INC (3)
Acrivon Therapeutics, Inc. (2)
Acutus Medical, Inc. (6)
ADNEXUS THERAPEUTICS, INC. (5)
Affinia Therapeutics Inc. (1)
AIT Therapeutics, Inc. (3)
ALLIED HEALTHCARE PRODUCTS INC (1)
ALLOS THERAPEUTICS INC (2)
Alphatec Holdings, Inc. (17)
ANTARES PHARMA, INC. (1)
Apogee Therapeutics, Inc. (5)
Apollo Endosurgery, Inc. (2)
APPYEA, INC (2)
AquaMed Technologies, Inc. (6)
ARATANA THERAPEUTICS, INC. (12)
ARGOS THERAPEUTICS INC (9)
Arno Therapeutics, Inc (3)
ARYx Therapeutics, Inc. (1)
AtriCure, Inc. (1)
Audentes Therapeutics, Inc. (7)
AV Therapeutics, Inc. (1)
AxoGen, Inc. (9)
Axonics Modulation Technologies, Inc. (3)
BARRIER THERAPEUTICS INC (4)
Bellerophon Therapeutics, Inc. (1)
BIOCANCELL THERAPEUTICS INC. (1)
BIOLASE, INC (2)
BIOMIMETIC THERAPEUTICS, INC. (1)
Bionik Laboratories Corp. (3)
BioSig Technologies, Inc. (3)
Bioventus Inc. (4)
Bluejay Diagnostics, Inc. (2)
Boston Scientific (2)
BRAIN SCIENTIFIC INC. (1)
Cadrenal Therapeutics, Inc. (1)
Cardiovascular Systems Inc (4)
Cascadian Therapeutics, Inc. (5)
CERUS CORP (1)
CESCA THERAPEUTICS INC. (4)
Chelsea Therapeutics International, Ltd. (1)
CHEMBIO DIAGNOSTICS, INC. (3)
CHF Solutions, Inc. (2)
Co-Diagnostics, Inc. (1)
Colfax CORP (1)
Conformis Inc (2)
CORNERSTONE THERAPEUTICS INC (36)
Coya Therapeutics, Inc. (2)
CryoLife, Inc. (1)
CV THERAPEUTICS INC (2)
Cynapsus Therapeutics Inc. (1)
Dare Bioscience, Inc. (15)
DELCATH SYSTEMS, INC. (3)
Dimension Therapeutics, Inc. (3)
Echo Therapeutics, Inc. (7)
Edwards Lifesciences (2)
EKSO BIONICS HOLDINGS, INC. (3)
Elicio Therapeutics, Inc. (1)
EMBER THERAPEUTICS, INC. - NY (3)
EMULATE THERAPEUTICS, INC. (5)
ENCISION INC (1)
ENDOLOGIX INC (1)
Envista Holdings Corp (2)
ERBA Diagnostics, Inc. (1)
GenMark Diagnostics, Inc. (19)
GLAUKOS Corp (2)
Glolex, Inc. (3)
Glucose Biosensor Systems (Greater China) Holdings, Inc. (7)
GUIDED THERAPEUTICS INC (1)
HealthCor Catalio Acquisition Corp. (2)
Heart Test Laboratories, Inc. (12)
HELIUS MEDICAL TECHNOLOGIES, INC. (1)
Heska Corporation (12)
Holly Brothers Pictures, Inc. (2)
Hologic (2)
HYPERION THERAPEUTICS INC (1)
HYPERTENSION DIAGNOSTICS INC (2)
Innovative Eyewear Inc (2)
Inogen, Inc. (2)
InspireMD, Inc. (4)
INSULET CORP (7)
INTARCIA THERAPEUTICS, INC (6)
INTROGEN THERAPEUTICS INC (3)
Intuitive Surgical Inc. (1)
INVIVO THERAPEUTICS HOLDINGS CORP. (3)
INVO Bioscience, Inc. (1)
Juno Therapeutics, Inc. (16)
LeMaitre Vascular, Inc. (3)
Lucid Diagnostics Inc. (2)
Lucira Health, Inc. (1)
MABVAX THERAPEUTICS HOLDINGS, INC. (1)
Masimo (3)
Medifirst Solutions, Inc. (1)
MELINTA THERAPEUTICS, INC. (10)
METABASIS THERAPEUTICS INC (1)
Mineralys Therapeutics, Inc. (1)
MINERVA SURGICAL INC (3)
MISONIX INC (2)
MRI INTERVENTIONS, INC. (24)
MYOMO INC (2)
NanoVibronix, Inc. (1)
Nemaura Medical Inc. (2)
Neogen Corporation (2)
Neon Therapeutics, Inc. (2)
Neumora Therapeutics, Inc. (8)
NeuroMetrix, Inc. (2)
NEUROONE MEDICAL TECHNOLOGIES Corp (4)
NEVRO CORP (2)
NOVELION THERAPEUTICS INC. (2)
OBALON THERAPEUTICS INC (1)
Ocera Therapeutics, Inc. (6)
OraSure Technologies, Inc. (1)
Orexigen Therapeutics, Inc. (4)
OSIRIS THERAPEUTICS, INC. (2)
Oxford Immunotec Global PLC (1)
OxySure Therapeutics, Inc. (4)
OZOP SURGICAL CORP. (1)
Peloton Therapeutics, Inc. (1)
PERNIX THERAPEUTICS HOLDINGS, INC. (1)
PetVivo Holdings, Inc. (1)
Precision Therapeutics Inc. (1)
Primus Therapeutics Inc. (2)
PRO DEX INC (1)
PROCEPT BioRobotics Corp (2)
Pulse Biosciences, Inc. (7)
Q Therapeutics, Inc. (1)
QUANTRX BIOMEDICAL CORP (2)
Ra Medical Systems, Inc. (2)
REMEDENT, INC. (6)
REPROS THERAPEUTICS INC. (1)
ReShape Lifesciences Inc. (6)
Restoration Robotics, Inc. (6)
RETRACTABLE TECHNOLOGIES INC (1)
ReWalk Robotics Ltd. (2)
ROCKWELL MEDICAL, INC. (3)
RTI Surgical Holdings, Inc. (1)
RTI SURGICAL, INC. (3)
RxSight, Inc. (3)
Sandbridge Acquisition Corp (1)
SANUWAVE Health, Inc. (1)
SECOND SIGHT MEDICAL PRODUCTS INC (2)
Silk Road Medical Inc (5)
Sintx Technologies, Inc. (4)
Spark Therapeutics, Inc. (3)
STEMLINE THERAPEUTICS INC (9)
STRATA Skin Sciences, Inc. (1)
Surmodics, Inc. (1)
Synvista Therapeutics, Inc. (3)
TACTILE SYSTEMS TECHNOLOGY INC (1)
Talon Therapeutics, Inc. (6)
TANDEM DIABETES CARE INC (1)
Targanta Therapeutics Corp. (1)
TearLab Corp (8)
TELA Bio, Inc. (5)
The Cooper Companies (1)
Tobira Therapeutics, Inc. (8)
TRANSENTERIX INC. (2)
Varex Imaging Corporation (1)
Varian Medical Systems (1)
VERMILLION, INC. (2)
Vidara Therapeutics International Ltd (6)
ViewRay, Inc. (12)
Vividion Therapeutics, Inc. (1)
VOLITIONRX LTD (4)
WOUND MANAGEMENT TECHNOLOGIES, INC. (6)
Zander Therapeutics, Inc (1)
Zimmer Biomet Holdings (1)
ZimVie Inc. (1)

Recent Contracts

Exclusive License Agreement, dated September 19, 2023, by and between ReShape Lifesciences Inc. and Biorad Medysis Pvt. Ltd (OBALON THERAPEUTICS INC, Filed With SEC on September 22, 2023)
License: Electrocardiogram Deep Learning Interpretability Toolbox (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Diagnosis of STEMI using a model derived from a foundational vision transformer (HeartBEiT) (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Diagnosis of Hypertrophic Cardiomyopathy using a model derived from a foundational vision transformer (HeartBEiT) (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Derivation of low Left Ventricular Ejection fraction based on a foundational vision transformer (HeartBEiT) (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Deep learning for electrocardiograms to identify left heart valvular dysfunction mitral regurgitation (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Deep learning for electrocardiograms to identify left heart valvular dysfunction - aortic stenosis (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Prediction of right ventricular size and systolic function from the 12-lead ECG (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Deep Learning on ECGs to Derive Left and Right Ventricular Function (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Deep Learning Algorithm to Predict PVC-Related Cardiomyopathy (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
License: Pulmonary Embolism Detection From the Electrocardiogram Using Deep Learning (Heart Test Laboratories, Inc., Filed With SEC on September 21, 2023)
First Amendment to Exclusive License Agreement for GCase, dated June 14, 2022, by and between the Registrant and Amgen, Inc (Neumora Therapeutics, Inc., Filed With SEC on September 11, 2023)
First Amendment to License Agreement, dated July 17, 2023, by and between the Registrant and Vanderbilt University (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
License Agreement, dated February 10, 2022, by and between the Registrant and Vanderbilt University (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
Second Amendment to License Agreement, dated April 9, 2019, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
First Amendment to License Agreement, dated November 13, 2017, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
License Agreement, dated November 23, 2015, by and between BlackThorn Therapeutics, Inc. and Scripps Research Institute (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
Exclusive License Agreement for GCase, dated September 10, 2021, by and between the Registrant and Amgen Inc (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
Exclusive License Agreement for CK1d, dated September 10, 2021, by and between the Registrant and Amgen Inc (Neumora Therapeutics, Inc., Filed With SEC on August 25, 2023)
Amendment No. 2 License Agreement by and between Heart Test Laboratories, Inc. and The University Court of The University of Glasgow, dated March 31, 2023 (Heart Test Laboratories, Inc., Filed With SEC on July 19, 2023)
Cell Line License Agreement, effective as of June 20, 2022, by and between Paragon Therapeutics, Inc. and WuXi Biologics (Hong Kong) Limited (Apogee Therapeutics, Inc., Filed With SEC on June 22, 2023)
OX40L License Agreement, dated April 28, 2023, by and between Paragon Therapeutics, Inc. and Apogee Biologics, Inc. (f/k/a Apogee Therapeutics, Inc.) (Apogee Therapeutics, Inc., Filed With SEC on June 22, 2023)
IL-4R License Agreement, dated April 3, 2023, by and between Paragon Therapeutics, Inc. and Apogee Biologics, Inc. (f/k/a Apogee Therapeutics, Inc.) (Apogee Therapeutics, Inc., Filed With SEC on June 22, 2023)
Amendment No. 1 to IL-13 License Agreement, dated November 10, 2022, by and between Paragon Therapeutics, Inc. and Apogee Biologics, Inc. (f/k/a Apogee Therapeutics, Inc.) (Apogee Therapeutics, Inc., Filed With SEC on June 22, 2023)
IL-13 License Agreement, dated November 4, 2022, by and between Paragon Therapeutics, Inc. and Apogee Biologics, Inc. (f/k/a Apogee Therapeutics, Inc.) (Apogee Therapeutics, Inc., Filed With SEC on June 22, 2023)
License Agreement, dated as of January 4, 2023, by and between Bellerophon Therapeutics, Inc. and Baylor BioSciences, Inc (Bellerophon Therapeutics, Inc., Filed With SEC on May 15, 2023)
First Amendment to License Agreement dated as of May 8, 2023 between Cordis US Corp., as successor to Cordis Corporation, and Silk Road Medical, Inc (Silk Road Medical Inc, Filed With SEC on May 9, 2023)
Amendment No. 3 to the Amended and Restated Exclusive License Agreement, effective as of February 13, 2017, by and among Fred Mermelstein, Ph.D., and Janet Chollet, M.D., Pear... (Dare Bioscience, Inc., Filed With SEC on March 30, 2023)
License and Distribution Agreement with SeaStar Medical Holding Corporation, dated as of December 27, 2022 (CHF Solutions, Inc., Filed With SEC on March 3, 2023)
Confidential Exclusive Patent License and Covenant Not to Sue, by and between the Registrant and HydroCision, Inc., dated March 14, 2019 (PROCEPT BioRobotics Corp, Filed With SEC on February 28, 2023)
Patent Assignment and License Agreement, dated February 9, 2023, between Insulet Corporation, Bigfoot Biomedical, Inc. and Patients Pending, Ltd (INSULET CORP, Filed With SEC on February 14, 2023)
License Agreement, dated July 9, 2020, between the Registrant and Mitsubishi Tanabe Pharmaceutical Corporation (Mineralys Therapeutics, Inc., Filed With SEC on January 18, 2023)
License Agreement by and between Coya Therapeutics, Inc. and ARScience Biotherapeutics, Inc., dated August 23, 2022. (c)(d) (Coya Therapeutics, Inc., Filed With SEC on November 18, 2022)
Amended and Restated Patent Know How and License Agreement, effective as of October 6, 2020, by and between Coya Therapeutics, Inc. and The Methodist Hospital(c)(d) (Coya Therapeutics, Inc., Filed With SEC on November 18, 2022)
Patent License Agreement, by and between the Registrant and Peter Blume-Jensen, dated April 12, 2018 (Acrivon Therapeutics, Inc., Filed With SEC on October 17, 2022)
License Agreement, by and between the Registrant and Eli Lilly and Company, dated January 27, 2021 (Acrivon Therapeutics, Inc., Filed With SEC on October 17, 2022)
License, Development and Commercialization Agreement Effective as of September 16, 2015 by and between Armetheon, Inc. and China Cardiovascular Focus Ltd (Cadrenal Therapeutics, Inc., Filed With SEC on October 11, 2022)
Real Estate License Agreement, dated as of September 1, 2022, by and among certain subsidiaries of Neogen Corporation, 3M Company and certain of its subsidiaries (Neogen Corporation, Filed With SEC on September 1, 2022)
Trademark Transitional License Agreement, dated as of September 1, 2022, by and among 3M Company, 3M Innovative Properties Company, Neogen Corporation and Garden SpinCo Corporation (Neogen Corporation, Filed With SEC on September 1, 2022)
Eighth Amendment to License and Services Agreement, dated as of August 22, 2022, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services) (AxoGen, Inc., Filed With SEC on August 25, 2022)